Read PPLA’s latest announcements, statements, and press releases on our work to protect patient safety and preserve printed medication information.
-
PPLA Highlights the Danger of the FDA’s PMI Rule for Pharmacies During National Pharmacy Week
The Pharmaceutical Printed Literature Association (PPLA) celebrates National Pharmacy Week while addressing the crisis of ongoing pharmacy closures, particularly in rural areas. Nearly 29% of retail pharmacies closed from 2010 to 2021 due to rising costs and workforce shortages. The FDA’s proposed rule to shift Patient Medication Information to digital formats could further strain pharmacies,… Read More
Category: Press Release -
Building Momentum – National Support for the Patients’ Right to Know Their Medication Act
The Patients’ Right to Know Their Medication Act (H.R. 5133) aims to enhance patient safety by requiring standardized printed medication information with prescriptions. Supported by healthcare advocates, the bill emphasizes clear communication about side effects and dosing, ultimately aiming to reduce risks, hospital visits, and provide peace of mind to families. Read More
Category: Blog Post -
Rural Voices Matter – Why This Bill Protects Communities Most at Risk
In rural Oregon, Congressman Cliff Bentz advocates for the Patients’ Right to Know Their Medication Act (H.R. 5133), highlighting its importance in addressing pharmacy closures and internet access issues. The act mandates manufacturers to fund printed medication information, ensuring rural patients receive crucial medication guidance for safer healthcare. Read More
Category: Blog Post -
A Bipartisan Win for Patients – The Reintroduction of the Patients’ Right to Know Their Medication Act
Patients in America need accessible information about their medications. Proposed FDA changes may jeopardize this by moving Patient Medication Information online, disadvantaging those without internet access. Representatives Bentz and Golden’s Patients’ Right to Know Their Medication Act mandates printed information sheets with prescriptions, enhancing safety and reducing errors, particularly for rural patients. Read More
Category: Blog Post -
PPLA Releases Critical White Paper Opposing FDA’s Prescription Drug Labeling Overhaul
The Pharmaceutical Printed Literature Association’s report critiques the FDA’s proposed prescription drug labeling changes, warning they could impose significant costs on community pharmacies with minimal benefits for patients. It highlights risks to patient comprehension, privacy, and health equity, urging regulators to collaborate with pharmacies for evidence-based solutions before implementation. Read More
Category: Press Release